Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 6,685 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Silexion Therapeutics Corporation | SLXNW | NASDAQ | Warrant Capital Accionario |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.0006 | -2.75% | 0.0212 | 12:42:03 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.0218 | 0.0212 | 0.0253 | 0.0218 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
|---|---|---|---|---|
| 8 | 6,685 | 0.0219456 | 147 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 12:42:03 | 400 | 0.0212 | USD |
Información Financiera Silexion Therapeutics Corporation SLXNW
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 33.99k | - | - | - | 0.51 |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Silexion Therapeutics Corporation SLXNW
| Fecha | Hora | Fuente | Noticia |
|---|---|---|---|
| 29/11/2024 | 05:06 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 29/11/2024 | 05:05 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 29/11/2024 | 05:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 27/11/2024 | 05:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/11/2024 | 15:34 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 22/11/2024 | 15:32 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 22/11/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20/11/2024 | 05:15 | Edgar (US Regulatory) | Form SC 13D - General Statement of Acquisition of Beneficial.. |
| 19/11/2024 | 15:10 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 19/11/2024 | 15:08 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 19/11/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14/11/2024 | 08:03 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico SLXNW
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
